论文部分内容阅读
最近几年内才发现了对结核病原体具有特效的制剂。只有在这些制剂发现以后,才真正出现了用综合疗法治疗结核病患者的可能性。作为综合疗法的必要原则,除加强患者体力(即加强防御和消除最强烈的病理生理方面的失调)尚应作用於疾病原因上。结核病患者的综合疗法,在某些情形下,应包括直接针对顽固性病灶的外科手术。从广义言之,也可以把链霉素列入化学疗法制剂之内。链霉素是一种放线菌属的生活产物,是将其培养在一定的培养基上而取得。目前已了解到链霉素的化学分子式,当前的问题
In recent years, only those agents that have special effects on tuberculosis have been found. Only after these agents have been discovered will there be a real possibility of treating patients with tuberculosis with combination therapy. As a necessary principle of combination therapies, apart from strengthening patient physical strength (ie strengthening defenses and eliminating the strongest pathophysiological disorders), should still be applied to the cause of the disease. The combined treatment of TB patients, in some cases, should include surgery directed against refractory lesions. In broad terms, streptomycin can also be included in chemotherapeutic agents. Streptomycin is a living product of actinomycetes obtained by culturing it on a certain medium. Now know the chemical formula of streptomycin, the current problem